Atlas Trials

Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease

Clinical trial NCT01042509 · COMPLETED

Trial details

NCT number
NCT01042509
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2009-10-01
Primary completion
2011-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.